CoChat

Long-term Outcome After Acute Treatment with: Alprazolam or Clonazepam for Panic Disorder

POLLACK, MARK H., OTTO, MICHAEL W., TESAR, GEORGE E., COHEN, LEE S., MELTZER-BRODY, SAMANTHA, ROSENBAUM, JERROLD F. · 1993 · Journal of Clinical Psychopharmacology
Cited by 77

The DOI matches its Crossref record.

Abstract

The relative effectiveness of the available treatments for panic disorder may best be understood in the context of the longitudinal course of the disorder. This study examines a number of clinically relevant issues, including long-term outcome after acute treatment, the proportion of patients remaining on single-agent treatment or requiring multiple medications or nonpharmacologic interventions over time, evidence for dose escalation during maintenance high-potency benzodiazepine therapy, and predictors of acute and long-term response to treatment. Fifty-nine panic disorder patients originally randomized to treatment in a controlled trial comparing alprazolam, clonazepam, and placebo were reevaluated in a follow-up study. At a mean follow-up of 1.5 years, 78% of patients remained on medication and the mean dosage of alprazolam and clonazepam did not increase. Our data suggest that most patients maintain benefit with long-term pharmacotherapy but that residual symptomatology may require more intensive or additional treatment strategies. Response at the endpoint of the acute trial was significantly associated with pretrial baseline Clinical Global Impression Scale score and the presence of dysthymia. Poor outcome at follow-up was associated with total duration of the disorder, agoraphobic subtype, and the presence of comorbid social phobia. We underscore the potential importance of comorbid affective and anxiety disorders as well as phobic patterns in determining long-term response to treatment.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1097/00004714-199308000-00005

Cites

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cited by

See all 77

Metadata

Authors
POLLACK, M. H., OTTO, M. W., TESAR, G. E., COHEN, L. S., MELTZER-BRODY, S., & ROSENBAUM, J. F.
Venue
Journal of Clinical Psychopharmacology
Published
1993-08
Volume
13
Issue
4
Pages
257???263
ISSN
0271-0749 (ISSN-L)
OpenAlex
W2046840283
Cited by
77
References
0
FWCI
7.46
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Long-term Outcome After Acute Treatment with: Alprazolam or Clonazepam for Panic Disorder. https://app.cochat.ai/papers/10.1097/00004714-199308000-00005
The paper
POLLACK, M. H., OTTO, M. W., TESAR, G. E., COHEN, L. S., MELTZER-BRODY, S., & ROSENBAUM, J. F. (1993). Long-term Outcome After Acute Treatment with: Alprazolam or Clonazepam for Panic Disorder. Journal of Clinical Psychopharmacology. https://doi.org/10.1097/00004714-199308000-00005

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.